A Test for Multiple Binary Endpoints with Continuous Latent Distribution in Clinical Trials
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2214-1766
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
A Test for Multiple Binary Endpoints with Continuous Latent Distribution in Clinical Trials ; volume:20 ; number:4 ; day:13 ; month:10 ; year:2021 ; pages:463-480 ; date:12.2021
Journal of Statistical Theory and Applications ; 20, Heft 4 (13.10.2021), 463-480, 12.2021
- Urheber
-
Ishihara, Takuma
Yamamoto, Kouji
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s44199-021-00003-3
- URN
-
urn:nbn:de:101:1-2022020607461317431979
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 15.08.2025, 07:25 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ishihara, Takuma
- Yamamoto, Kouji
- SpringerLink (Online service)
Ähnliche Objekte (12)
A retrospective analysis of conditional power assumptions in clinical trials with continuous or binary endpoints
Internal pilot study design in clinical trials with multiple binary endpoints
Optimal futility stopping boundaries for binary endpoints
Efficient confidence limits for adaptive one-arm two-stage clinical trials with binary endpoints
Testing non-inferiority of a new treatment in three-arm clinical trials with binary endpoints
A flexible design for advanced Phase I/II clinical trials with continuous efficacy endpoints
The Bayesian Group-Sequential Predictive Evidence Value Design for Phase II Clinical Trials with Binary Endpoints
Endpoints for clinical trials in retinal diseases
A Bayesian semiparametric latent variable model for binary, ordinal and continuous response
Interim analysis incorporating short‐ and long‐term binary endpoints
Efficacy Endpoints in Clinical Trials in Actinic Keratosis
Endpoints for Pharmacotherapy Trials for Alcohol Use Disorder
A retrospective analysis of conditional power assumptions in clinical trials with continuous or binary endpoints
Internal pilot study design in clinical trials with multiple binary endpoints
Optimal futility stopping boundaries for binary endpoints
Efficient confidence limits for adaptive one-arm two-stage clinical trials with binary endpoints
Testing non-inferiority of a new treatment in three-arm clinical trials with binary endpoints
A flexible design for advanced Phase I/II clinical trials with continuous efficacy endpoints
The Bayesian Group-Sequential Predictive Evidence Value Design for Phase II Clinical Trials with Binary Endpoints
Endpoints for clinical trials in retinal diseases
A Bayesian semiparametric latent variable model for binary, ordinal and continuous response
Interim analysis incorporating short‐ and long‐term binary endpoints
Efficacy Endpoints in Clinical Trials in Actinic Keratosis
Endpoints for Pharmacotherapy Trials for Alcohol Use Disorder
A retrospective analysis of conditional power assumptions in clinical trials with continuous or binary endpoints
Internal pilot study design in clinical trials with multiple binary endpoints
Optimal futility stopping boundaries for binary endpoints
Efficient confidence limits for adaptive one-arm two-stage clinical trials with binary endpoints
Testing non-inferiority of a new treatment in three-arm clinical trials with binary endpoints
A flexible design for advanced Phase I/II clinical trials with continuous efficacy endpoints
The Bayesian Group-Sequential Predictive Evidence Value Design for Phase II Clinical Trials with Binary Endpoints
Endpoints for clinical trials in retinal diseases
A Bayesian semiparametric latent variable model for binary, ordinal and continuous response
Interim analysis incorporating short‐ and long‐term binary endpoints
Efficacy Endpoints in Clinical Trials in Actinic Keratosis